CorMedix (CRMD) Tops Q3 EPS by 7c

CorMedix (NASDAQ: CRMD) reported Q3 EPS of ($0.17), $0.07 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $6.81 million .

For earnings history and earnings-related data on CorMedix (CRMD) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Lynx Equity sees Micron and SanDisk breakout as volatility normalizes
• RBC Capital Reiterates Outperform Rating on Aviva PLC (AV:LN) (AVVIY)